A detailed history of Pacer Advisors, Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Pacer Advisors, Inc. holds 561,586 shares of RPRX stock, worth $20.3 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
561,586
Holding current value
$20.3 Million
% of portfolio
0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 15, 2025

BUY
$34.9 - $37.91 $19.6 Million - $21.3 Million
561,586 New
561,586 $19.8 Million
Q2 2024

Aug 13, 2024

BUY
$26.26 - $29.9 $355,507 - $404,786
13,538 Added 59.34%
36,353 $958,000
Q1 2024

May 10, 2024

BUY
$27.46 - $31.33 $400,311 - $456,728
14,578 Added 176.98%
22,815 $692,000
Q4 2023

Jan 16, 2024

BUY
$26.21 - $29.22 $109,479 - $122,051
4,177 Added 102.88%
8,237 $231,000
Q3 2023

Nov 13, 2023

BUY
$26.26 - $31.38 $106,615 - $127,402
4,060 New
4,060 $110,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $15.8B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.